今天3分钟我们来聊聊鼻喷外泌体,精神科诊疗新突破源于细胞BioInsid的个人播客

今天3分钟我们来聊聊鼻喷外泌体,精神科诊疗新突破

12分钟 ·
播放数2
·
评论数0

精神类疾病诊疗长期存在诊断模糊、药物起效慢副作用大的痛点,科研团队发现外泌体可穿越血脑屏障,既能作为液体活检工具辅助精准诊断,还能通过鼻腔递送药物快速改善抑郁等症状,目前相关研究仍处于早期动物实验阶段。

参考文献:

  1. 《药学进展》综述:《外泌体用于精神科疾病诊疗的研究进展》(上海精神卫生中心+上海交大药学院),DOI: 10.20053/j.issn1001-5094.20250032 PDF

  2. Wei et al. (2020) "Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis" Neuropsychopharmacology 45(6):1050-1058 PMC

  3. Zhong et al. (2024) "Unlocking the therapeutic potential of exosomes derived from nasal olfactory mucosal mesenchymal stem cells" Schizophrenia Bulletin 50(3):600-614

  4. Madhu et al. (2025) "Intranasal Human NSC-Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS-STING Signaling, in Aged Hippocampus" bioRxiv DOI:10.1101/2025.03.02.641082 PubMed